Warner Chilcott (US), LLC v. Teva Pharmaceuticals USA, Inc.
1:15-cv-00761
Overview
Parties
Defendant
Teva Pharmaceutical Industries Ltd. Operating Company
Represented By
0 Attorneys ListedTeva Pharmaceuticals USA, Inc. Operating Company
Represented By
0 Attorneys ListedPlaintiff
Qualicaps Co., Ltd. Operating Company
Represented By
3 Attorneys ListedAshby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Warner Chilcott Company, LLC Operating Company
Represented By
3 Attorneys ListedAshby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Warner Chilcott (US), LLC Operating Company
Represented By
3 Attorneys ListedAshby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 3 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | Asserted Patent | View Official Patent → |
| π―π΅ Japan | Japan Counterpart | View Official Patent → | |
| π―π΅ Japan | Japan Counterpart | View Official Patent → |
Mylan Pharmaceuticals Inc. v. Qualicaps Co., Ltd.
Warner Chilcott (US), LLC v. Zydus Pharmaceuticals (USA) Inc.
Warner Chilcott (US), LLC v. Mylan Pharmaceuticals, Inc.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6649180
Hard capsule formed of cellulose ether film with a specific content of methoxyl and hydroxypropoxyl groups
|
Filed: 2000-04-13
Issued: 2003-11-18
|
Expired (Term Ended)
Expires: 2020-04-13
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).